Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization.
about
Overutilization of proton-pump inhibitors: what the clinician needs to knowManaging medications in clinically complex elders: "There's got to be a happy medium".Proton pump inhibitors and the risk of pneumonia: a comparison of cohort and self-controlled case series designsInappropriate use of proton pump inhibitors in a local settingEvaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart reviewEffects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoeaProton Pump Inhibitor use in Hospitalized Patients: Is Overutilization Becoming a Problem?ePrescribing: Reducing Costs through In-Class Therapeutic Interchange.Omeprazole promotes carcinogenesis of fore-stomach in mice with co-stimulation of nitrosamineA Successful Pharmacist-Based Quality Initiative to Reduce Inappropriate Stress Ulcer Prophylaxis Use in an Academic Medical Intensive Care Unit.Long-Term PPI Use: Balancing Potential Harms and Documented Benefits.Quantifying Candidacy for Deprescribing of Proton Pump Inhibitors among Long-Term Care Residents
P2860
Q24634086-421C44FD-51B7-4BAC-9779-E68A67CB22AAQ34311242-BA297DE3-0520-4DC0-B540-F1448963EF57Q34783099-8EAB8352-6F58-481E-8DD2-38156611AF77Q34929084-C34BD09C-B32A-4E54-A982-CD51C3018996Q35571775-B76F4C4D-DD4F-4A4B-B516-DDABDABE38A3Q36140398-52FC6973-031D-4F5C-9995-C5685E814763Q37704535-F8CF9422-E17A-47B1-A4D3-4A89C500A262Q39103163-04E14293-0170-43A9-A0D9-5107CD6EA713Q42378432-560D1EA4-2614-48F8-92DE-7C9F22308088Q52675338-AD876F27-0901-4242-A508-98104A654C6DQ53114979-8B4978A2-BA5E-4EA6-8A1F-310FE682B596Q58557250-E607A0ED-FCF9-4DA7-BAFC-2C2CBF357330
P2860
Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Longitudinal analysis of the c ...... rge managed care organization.
@en
Longitudinal analysis of the c ...... rge managed care organization.
@nl
type
label
Longitudinal analysis of the c ...... rge managed care organization.
@en
Longitudinal analysis of the c ...... rge managed care organization.
@nl
prefLabel
Longitudinal analysis of the c ...... rge managed care organization.
@en
Longitudinal analysis of the c ...... rge managed care organization.
@nl
P2093
P1476
Longitudinal analysis of the c ...... rge managed care organization.
@en
P2093
Eric J Culley
Lisa Thomas
Patricia Gladowski
Sarah M Marche
Vickie Goff
P304
P356
10.18553/JMCP.2010.16.2.122
P577
2010-03-01T00:00:00Z